Noramco, LLC: Noramco Announces Submission and Reactivation of the Drug Master File for Active Pharmaceutical Ingredient Methylnaltrexone Bromide
Leverages Company's Extensive Experience in the Complex Synthesis of Naltrexone-related Products Vertically Integrated Approach Ensures Exceptional Supply Chain Security Noramco, LLC, a leading
Source: finanznachrichten.de